Cargando…
Locomotor and histological changes in a cuprizone-induced animal model of multiple sclerosis: comparison between alpha-tocopherol and fingolimod
BACKGROUND AND PURPOSE: Fingolimod is a sphingosine 1-phosphate receptor modulator used to treat multiple sclerosis (MS). Alpha-tocopherol (AT) has been found to improve motor function in an animal model of MS. In the present study, the effects of AT and fingolimod on the locomotor function and hist...
Autores principales: | Mitra, Nilesh Kumar, Singh, Nermesh Singh A/L Gurdib, Wadingasafi, Nurul Ain Najihah Binti, Chellian, Jestin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860104/ https://www.ncbi.nlm.nih.gov/pubmed/35280835 http://dx.doi.org/10.4103/1735-5362.335172 |
Ejemplares similares
-
Evaluation of neuroprotective effects of alpha-tocopherol in cuprizone-induced demyelination model of multiple sclerosis
por: Mitra, Nilesh Kumar, et al.
Publicado: (2020) -
Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice
por: Li, Siyao, et al.
Publicado: (2023) -
Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil
por: Rajinikanth, Paruvathanahalli Siddalingam, et al.
Publicado: (2016) -
Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis – Association and Prediction
por: Løken-Amsrud, Kristin I., et al.
Publicado: (2013) -
Histological and Top-Down Proteomic Analyses of the Visual Pathway in the Cuprizone Demyelination Model
por: Almuslehi, Mohammed S. M., et al.
Publicado: (2022)